Trials / Completed
CompletedNCT01708473
Feasibility Study: Compare the Effectiveness Between Two Pain Medications When Used Prior to Ultherapy™ Treatments
Feasibility Study: Comparison Of Advil® Vs. Lortab® For Reducing Discomfort Associated With Ultherapy™ Treatment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Ulthera, Inc · Industry
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study will compare the effectiveness of two pain medications for reducing discomfort during an Ultherapy treatment.
Detailed description
This trial is a prospective, single-site, double-blinded, randomized trial. All study subjects will receive a full face and neck Ultherapy treatment. Subjects will be randomized to receive one of two pain medications prior to treatment. Each subject will be asked to rate the level of discomfort during the Ultherapy treatment. All study subjects will be followed for 90 days following treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Advil | One (1) tablet 800 mg Advil one hour prior to treatment. |
| DRUG | Lortab | One (1) tablet 10/500 mg of Lortab one hour prior to treatment. |
| DEVICE | Ulthera System Treatment | Focused ultrasound energy delivered below the surface of the skin |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2012-02-01
- Completion
- 2012-02-01
- First posted
- 2012-10-17
- Last updated
- 2017-11-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01708473. Inclusion in this directory is not an endorsement.